Publications

5808 Results

Cancer prevention clinical trials: assessing for disparities in recruitment in Hawaii

Authors
E Bantum;I Cheng;K Cassel;L Kaopua;J Berenberg
Journal / Conference
Frontiers in Cancer Prevention Research, AACR, abstract #B26, p. 116 (poster presentation)
Year
2009
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217

Final pooled comparative outcomes analysis of JCOG 9511 and SWOG 0124, phase III trials of cisplatin + irinotecan vs. cisplatin + etoposide in extensive stage small cell lung cancer

Authors
PN Lara;K Chansky;T Shibata;H Fukuda;T Tamura;J Saijo;HJ Lenz;R Natale;J Crowley;M Redman;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl 1, abst. D5.7, S396, 2009 (IASLC 13th World Conf on Lung Cancer, oral pres);
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0124

Biomarkers of polycyclic aromatic hydrocarbon-DNA damage and cigarette smoke exposure

Authors
RM Santella;Y-J Zhang;Q Wang;M Redman;M Reid;W Davis;DR Gandara;C Powell;K Albain;C Ambrosone
Journal / Conference
Journal of Thoracic Oncology, 4(9):suppl. 1, abst M39.2, S164 (IASLC 13th World Conf of Lung Cancer, oral presentation);
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0424

Molecular epidemiology of lung cancer

Authors
CB Ambrosone
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl 1, abst. M38.5, S163 (oral pres., IASLC 13th World Conf of Lung Cancer)
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0424

Role of EGFR pathway activation in never smoking patients with lung cancer

Authors
PC Mack
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl 1, abst. M39.3, S164 (oral presentation, 13th World Conference of Lung Cancer)
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0424

S0536: Carboplatin, paclitaxel, cetuximab and bevacizumab followed by cetuximab and bevacizumab maintenance in advanced non-small cell lung cancer (NSCLC), a SWOG phase II study

Authors
ES Kim;RS Herbst;J Moon;M Redman;S Dakhil;F Hirsch;P Mack;W Franklin;K Kelly;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl 1, abst. #PD3.5.5, S455; IASLC 13th World Conf on Lung Cancer, oral;
Year
2009
Research Committee(s)
Lung
Study Number(s)
S0536

S9900 trial update, mature analysis

Authors
KM Pisters;E Vallieres;P Bunn;J Crowley;K Chansky;D Gandara
Journal / Conference
Journal of Thoracic Oncology 4(9):suppl. 1, Abst. #E9.3, S201; 2009 (IASLC 13th World Conf on Lung Cancer, oral;
Year
2009
Research Committee(s)
Lung
Study Number(s)
S9900

Long-term survival analysis ofthe North American Intergroup study C9011 comparing fludarabine (f) and chlorambucil (c) in previously untreated patients with chronic lymphocytic leukemia (CLL)

Authors
K Rai;BL Peterson;FR Appelbaum;M Tallman;A Belch;VA Morrison;RA Larson
Journal / Conference
Blood 114:abstr #536 (ASH 2009 Annual Meeting, oral presentation)
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9108 (CALGB-9011)

The influence of older age on physician and patient decision-making regarding enrollment to breast cancer clinical trials

Authors
S Javid;J Unger;J Gralow;C Moinpour;A Wozniak;JW Goodwin;P Lara;P Williams;L Hutchins;C Gotay;K Albain
Journal / Conference
San Antonio Breast Cancer Symposium, poster, abst. #3077
Year
2009
Research Committee(s)
Cancer Survivorship
Study Number(s)
S0316

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine/cytarabine for relapsed/refractory acute lymphocytic leukemia

Authors
A Advani;H Gundacker;L Sala-Torra;J Radich;R Lai;J Lancet;S Coutre;RK Stuart;MP Mims;P Stiff;F Appelbaum
Journal / Conference
Blood 114:abst. #3094, 2009 (poster presentation)
Year
2009
Research Committee(s)
Leukemia
Study Number(s)
S0530